Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
about
Positive and negative functions of B lymphocytes in tumorsFunctional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesFcγ Receptors in Solid Organ TransplantationFasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity.Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodiesDeveloping multi-target therapeutics to fine-tune the evolutionary dynamics of the cancer ecosystem.Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma.Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity.Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses.Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice.Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer?Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.Cancer Immunotherapy: Whence and Whither.Novel immunotherapies for the treatment of melanoma.A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer.Systemic Immunity Is Required for Effective Cancer Immunotherapy.Roles for Innate Immunity in Combination Immunotherapies.Tumor-binding antibodies and tumor immunity.B lymphocytes and cancer: a love-hate relationship.Antitumor Antibodies Can Drive Therapeutic T Cell Responses.New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms.Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.Trial watch: Dendritic cell-based anticancer immunotherapy.Cancer: Antibodies regulate antitumour immunity.Immunotherapy: Put your coat on!Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer.Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation.Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
P2860
Q26743398-B9ACDD8A-09D8-4678-95D2-F2A988E73F80Q26777948-D53E35C4-F244-4698-B9BE-B32020C6EC38Q28076012-E3AD0BAF-5EA7-4CB6-9E5C-68543FF28ECFQ33554629-24946506-FD5B-43C8-8579-E7B8DCE24FDBQ33594333-0E33696B-C89A-4102-8C77-50746EF956FDQ35933820-0FE50E5E-6B7F-496C-9001-1F0978B3CEEEQ35999110-4F91684D-50DB-4582-B4BE-126FA64F0E82Q36097745-EC13F6A8-50C2-44E4-866B-9FB476865B56Q36742838-91C4668E-F38E-4E21-B13F-8E2BF67AB11CQ36821138-68FFC894-13F2-4E3D-8128-48A77CC6D906Q37377083-8B0E4D3D-2EDD-44A9-9A7F-FC09B76BB97BQ37398348-1E2007A7-6F27-4D82-A9E2-01822769862AQ37474087-09EC9B3F-794C-43DA-8DB6-5FDCC49D5E7FQ37554718-FFB1CA60-33C0-46DB-8375-00498D37879FQ37693346-C31AF12D-DFF2-45C5-9D9A-EE51D32BAD42Q37696132-14142298-FCC5-4596-998B-64C6C5D3EDB9Q38635910-562EB87A-6B56-46A6-958E-523F374F56FAQ38730777-240120FC-5446-47B3-A88B-92278F5B0375Q38737924-1368BDDE-12E1-4C32-A2AC-76AE382DDA46Q38824190-686F155B-D899-4710-8753-AD8DD2073C86Q38875025-CB6F2DD7-47B6-41BF-97CF-2851CC6CE43DQ39006805-1C17D64A-FBBD-43E0-A14F-8509B6CB20B2Q41996352-09A26497-B135-4A27-B85D-3756926B7178Q42552554-FF0DE22B-9D62-4F34-A1D1-436CD2E1B116Q44779139-D1B83F60-6ABC-4573-ABBF-F5B183AEF024Q47722599-F96EFA2F-2DCC-4AD0-87BE-B58C830431A3Q52641617-5D1F4129-5495-418F-AEBE-1037B7C7F3BDQ52757687-C36D5FF6-C872-4991-B9CF-F314809C55ACQ53109846-9B0DB693-AF72-46E7-AB86-33EB8C71E2D6Q53524931-F5A6B024-BBC8-4FCA-8BD2-B8AB824AF91FQ53912443-4449B405-9474-418B-98AB-5F51617EF49EQ54198584-D728B9FA-ACF3-46D3-8E82-A59F4987484EQ55079595-EFC28D24-A267-4055-A626-B0AD9081DA2CQ58722575-1733E0F0-1267-40F5-957F-405C1ADC22FA
P2860
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
@en
type
label
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
@en
prefLabel
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
@en
P2093
P2860
P356
P1433
P1476
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity
@en
P2093
Bryan M Burt
Edgar G Engleman
Ehud Segal
Ian L Linde
Justin A Kenkel
Matthew G Davidson
Nicola Perlman
Nupur Bhattacharya
Tyler R Prestwood
Yaron Carmi
P2860
P2888
P304
P356
10.1038/NATURE14424
P407
P577
2015-04-29T00:00:00Z
P5875
P6179
1047092281